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Verrucous carcinoma is a rare variant of well-differentiated
squamous cell carcinoma, and frequently arises in the
vulva as well as in the nasopharynx and larynx, but rarely
in the uterine cervix [1]. It is known to be radioresis-
tant and recur locally, but distant metastasis is rare
[2]. Diagnosis is notoriously difficult, because biopsied
material either is inadequate or may exhibit epithelial
maturation and a deceptive lack of cytologic atypia.
Human papillomavirus (HPV) strains, typically type
6 and its variants, have been reported to be associated
with verrucous carcinoma; however, HPV has not been
detected in many cases [2]. We present a case of uterine
cervical verrucous carcinoma involving the cervix in
which the Pap smear and HPV infection facilitated the
diagnosis, and discuss the difficulties in reaching a diag-
nosis on biopsy along with occasional histopathologic
misinterpretation that often lead to further delays in
diagnosis and treatment.
A 70-year-old woman, gravida 2, para 2, complained
of an abnormal vaginal discharge. Although the previ-
ous Pap cervical smear at a regional clinic had been
abnormal a few years previously, she had not sought
further examination. On pelvic examination, the cervix
had slight erosion and the uterus was atrophic. The
adnexa were normal and no lymphadenopathy was
noted. At our hospital, a Pap smear was performed and
diagnosed as Class IIIb (high-grade squamous intra-
epithelial lesion according to the Bethesda III system).
Colposcopy showed persistent acetic white changes
and prominent vascularity.
Umbilicated mosaic patterns with punctuation in
the middle of the tiles suggested cervical intraepithelial
neoplasia grade III (CIN III). Cervical punch biopsy
was performed and diagnosed as moderate dysplasia.
Because of the colposcopy findings and continuing
abnormal cytology of the cervix, conization was rec-
ommended and performed with informed consent.
Conization pathology demonstrated a hyperplastic
cervical mucosa composed of well-differentiated squa-
mous epithelium forming papillary structures lacking
central fibrovascular cores. Focal cytoplasmic vacuoliza-
tion was widely presented superficially. Koilocytosis and
gland involvement were found, and a well-demarcated
deep margin was notable for a broad, pushing edge.
Occasional mitotic figures were found in the basal lay-
ers. There was no stromal invasion. Histologic exami-
nation diagnosed verrucous carcinoma in situ (Figure).
Conization pathology suggested a residual tumor on
the stump. Hence, extended hysterectomy with pelvic
node sampling was performed following conization.
Microscopic examination did not show any residual
tumor and there was no nodal metastasis.
A cervical swab was tested for HPV DNA using the
polymerase chain reaction–restriction fragment length
polymorphism (PCR-RFLP) method prior to hysterec-
tomy. There was, however, no HPV detected. Following
the histologic diagnosis of the verrucous carcinoma
lesion, unstained paraffin sections were stained by
immunohistochemistry and there was no HPV antigen
detected in the present case.
Postoperatively, the patient had been doing well,
without evidence of tumor recurrence at the 10-month
postsurgical follow-up visit.
Verrucous carcinoma of the uterine cervix is a very
rare, specific, histologic type, and its slow growth
could cause a delay in diagnosis. Therefore, close com-
munication among the gynecologist, cytologist and
pathologist is required. Colposcopy typically does not
provide sufficient diagnostic information during the
incipient stage of the disease, because superficial tissue
biopsy cannot include sufficient amounts of verrucous
carcinoma and the cytologic criteria of malignancy may
typically be absent.
These histopathologic misinterpretations often lead to
further delays in diagnosis and treatment. Pantanowitz
et al reviewed 26 cases of uterine cervical verrucous
carcinoma and reported that 23% (six of 26 cases) of
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these showed a negative cervical smear [2]. Hando et al
also reported that the cytology of a verrucous cervical
carcinoma had been negative for 4 years and there was
a delay in diagnosis [3]. This high false-negative rate
on cytology might be brought about by the high degree
of orderly maturation and minimal or absent nuclear
atypia. However, the cytologic specimen obtained from
verrucous carcinoma could be diagnostically helpful in
many other cases as well as the present case.
A strong relation between uterine cervical dysplasia
or cancer and HPV infection has been firmly established.
It is indicated that HPV types 16 and 18 are associated
with uterine cervical squamous cell carcinoma (SCC),
whereas types 6, 11 and 16 are associated with warty
(condylomatous) carcinoma and condyloma acumi-
natum [1,4]. The particular HPV strains, typically type
6 and its variants, have been identified within verru-
cous carcinoma of the vagina [5]. However, HPV has not
been detected in many verrucous carcinomas, including
the present case. Including our case, HPV was not
detected using immunohistochemistry, PCR or PCR-
RFLP in 75% of reported cases (Table).
Robertson et al suggested that the detection of HPV
in verrucous genital lesions excludes the diagnosis of
verrucous carcinoma [11]. They questioned the need to
regard verrucous carcinoma as a variant of SCC, because
this lesion histologically and clinically resembles a giant
condyloma. Maeyama et al could not detect HPV anti-
gen by immunohistochemistry but found intranuclear
virus-like particles in koilocytotic cells in a case of cer-
vical verrucous carcinoma [6].
Although the present case failed to demonstrate
HPV infection, the possibility that HPV is the etiology
of verrucous carcinoma could not be excluded. Further
investigation of the possible role of HPV in uterine cer-
vical verrucous carcinoma is needed by accumulating
further cases and identifying distinct cytologic findings
to prevent delays in diagnosis and treatment.
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Figure. Histologic section of the cervix. (A) The tumor is characterized by large bulbous masses of squamous epithelium
invading in a “pushing” fashion (original magnification ×100). (B) Focal cytoplasmic vacuolization was widely presented superfi-
cially. Koilocytosis was found and the neoplastic squamous cells have almost no nuclear atypia (original magnification ×200).
Table. Human papillomavirus (HPV) status of reported cervical verrucous carcinoma cases. HPV has not been detected 
in many verrucous carcinomas, including the present case
Author Method Result
Maeyama et al [6] Immunohistology (−)
de Jesus et al [7] Immunohistology (−)
de Jesus et al [7] In situ hybridization (−)
Chen et al [8] PCR (−)
Matsumoto et al [1] PCR (−)
Zbroch et al [9] PCR HPV type 16
Pantanowitz et al [2] PCR (−)
Peng et al [10] Not mentioned in detail HPV types 11 and 53
Present case Immunohistology (−)
Present case PCR-RFLP (−)
(−) = negative; PCR = polymerase chain reaction; PCR-RFLP = polymerase chain reaction–restriction fragment length polymorphism.
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